ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,308.15
1.17%
Dow Jones
39,908.00
0.88%
US Dollar vs MXN
16.69289
-0.92%
Brent Oil
82.705
0.19%
Bitcoin
66,070.08
7.35%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Arena Pharmaceuticals Inc (ARNA)

  7. Arena Pharmaceuticals Inc (ARNA) Noticias

ARNA

Arena Pharmaceuticals (ARNA)

Arena Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ARNA
FechaHoraFuenteTítuloSímboloCompañía
16/03/202205:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARNAArena Pharmaceuticals Inc
11/03/202215:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARNAArena Pharmaceuticals Inc
11/03/202213:17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARNAArena Pharmaceuticals Inc
11/03/202208:38Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ARNAArena Pharmaceuticals Inc
11/03/202208:05Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:ARNAArena Pharmaceuticals Inc
11/03/202208:02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ARNAArena Pharmaceuticals Inc
11/03/202207:59Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ARNAArena Pharmaceuticals Inc
10/03/202205:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARNAArena Pharmaceuticals Inc
23/02/202216:00Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ARNAArena Pharmaceuticals Inc
23/02/202215:05Business WireArena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program UpdatesNASDAQ:ARNAArena Pharmaceuticals Inc
17/02/202215:05Business WireArena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ARNAArena Pharmaceuticals Inc
09/02/202215:05Business WireArena Pharmaceuticals to Release Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update on February 23NASDAQ:ARNAArena Pharmaceuticals Inc
21/01/202215:46Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ARNAArena Pharmaceuticals Inc
23/12/202116:26Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:ARNAArena Pharmaceuticals Inc
14/12/202106:31TipRanksLeerink Partners Downgrades Arena Pharma (ARNA) to HoldNASDAQ:ARNAArena Pharmaceuticals Inc
14/12/202106:30TipRanksAnalysts Have Conflicting Sentiments on These Healthcare Companies: Arena Pharma (ARNA), Global Blood Therapeutics (GBT) and Allogene Therapeutics (ALLO)NASDAQ:ARNAArena Pharmaceuticals Inc
14/12/202103:14TipRanksArena Pharmaceuticals Soars 80.4% on Pfizer’s $6.7B Acquisition DealNASDAQ:ARNAArena Pharmaceuticals Inc
13/12/202112:57Dow Jones NewsPfizer Shares Climb 5% Following Deal to Acquire Arena PharmaceuticalsNASDAQ:ARNAArena Pharmaceuticals Inc
13/12/202111:44Dow Jones NewsPfizer Deploying Some of Its Covid Cash in Arena Deal -- AnalysisNASDAQ:ARNAArena Pharmaceuticals Inc
13/12/202110:45TipRanksAnalyst Explains Why They Downgraded Their Rating on Arena Pharma (ARNA)NASDAQ:ARNAArena Pharmaceuticals Inc
13/12/202109:44Dow Jones NewsArena Pharmaceuticals Shares Surge on Takeover by PfizerNASDAQ:ARNAArena Pharmaceuticals Inc
13/12/202105:56Dow Jones NewsPfizer to Buy Arena Pharmaceuticals at $6.7 Billion ValueNASDAQ:ARNAArena Pharmaceuticals Inc
13/12/202105:45Business WirePfizer to Acquire Arena PharmaceuticalsNASDAQ:ARNAArena Pharmaceuticals Inc
01/12/202103:06TipRanksLeerink Partners Maintains Their Buy Rating on Arena Pharma (ARNA)NASDAQ:ARNAArena Pharmaceuticals Inc
19/11/202107:30Business WireArena Pharmaceuticals Achieves Target Enrollment for Etrasimod CULTIVATE Study ANASDAQ:ARNAArena Pharmaceuticals Inc
04/11/202115:05Business WireArena Reports Third Quarter Financial Results and Key Program UpdatesNASDAQ:ARNAArena Pharmaceuticals Inc
14/10/202115:05Business WireArena Pharmaceuticals to Release Third Quarter 2021 Financial Results and Provide Corporate Update on November 4NASDAQ:ARNAArena Pharmaceuticals Inc
02/09/202107:30Business WireArena Pharmaceuticals to Host Virtual R&D Investor Calls and Participate in Upcoming September Investor ConferencesNASDAQ:ARNAArena Pharmaceuticals Inc
05/08/202115:05Business WireArena Reports Second Quarter Financial Results and Key Program UpdatesNASDAQ:ARNAArena Pharmaceuticals Inc
05/08/202106:00PR Newswire (US)Second Genome Announces Collaboration with Arena Pharmaceuticals to Identify Gastrointestinal BiomarkersNASDAQ:ARNAArena Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ARNA

Su Consulta Reciente

NYSE
MRK
Merck
NYSE
VZ
Verizon Communications
NYSE
CVX
Chevron
NYSE
BAC
Bank of America
NASDAQ
NVDA
NVIDIA
NYSE
JPM
JP Morgan Chase
CCOM
SILVER
SILVER
USOTC
BASFY
BASF (QX)
USOTC
ADDYY
Adidas (QX)
CCOM
OILBRENT
Brent Oil
NYSE
KO
Coca Cola
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
AMZN
Amazon.com
AMEX
XLF
Financial Select Sector
USI
USTECH100
US Tech 100
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados